All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @kmartfit on TikTok · 28s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @kmartfit's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Most men are getting started on anywhere between about 90 milligrams of the sauschron upwards of 150 per week to see higher body response to that
  2. 0:07three months after you get started as a patient here at Harley Meds.
  3. 0:10We're going to take a blood test to see where your levels are and making sure they're working into that optimized range.
  4. 0:15And that's our whole goal here at Harley Meds is to make sure you're staying fully optimized.
  5. 0:19If you want to work with a clinic that truly cares about your health, doesn't just treat you like a freaking number,
  6. 0:23comment the word TRT down in the comments below and let's get you to switch over to Harley Meds ASAP.

What is the 'average' TRT dose, and does it matter for you?

KMART

TikTok creator

9.7K viewsWatch on TikTok

Quick answer

The creator promotes starting testosterone cypionate doses of 90-150mg weekly through their clinic, with a three-month blood test follow-up. While 90-100mg weekly aligns with Endocrine Society guidelines for initiating therapy, 150mg weekly as a universal starting dose exceeds what most guidelines recommend before baseline labs are reviewed. The follow-up bloodwork timeline cited is accurate and consistent with standard clinical monitoring protocols.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For What is the 'average' TRT dose, and does it matter for you?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

What is the 'average' TRT dose, and does it matter for you? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "What is the 'average' TRT dose, and does it matter for you?" from KMART. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator promotes starting testosterone cypionate doses of 90-150mg weekly through their clinic, with a three-month blood test follow-up.

The reason this review is not generic is the source wording and the canonical claim label "trt average dose of testosterone." In this clip, the useful excerpt is: "Most men are getting started on anywhere between about 90 milligrams of the sauschron upwards of 150 per week to see higher body response to that three months after you get started as a patient here at Harley Meds." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

75-100mg of testosterone cypionate or enanthate weekly is the most commonly cited evidence-based starting dose per Bhasin et al.
People who land here are usually trying to understand whether the Testosterone claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator promotes starting testosterone cypionate doses of 90-150mg weekly through their clinic, with a three-month blood test follow-up.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator promotes starting testosterone cypionate doses of 90-150mg weekly through their clinic, with a three-month blood test follow-up. While 90-100mg weekly aligns with Endocrine Society guidelines for initiating therapy, 150mg weekly as a universal starting dose exceeds what most guidelines recommend before baseline labs are reviewed. The follow-up bloodwork timeline cited is accurate and consistent with standard clinical monitoring protocols.
  • Endocrine Society 2018 guidelines recommend starting testosterone at doses that achieve mid-normal serum levels (roughly 400-700 ng/dL), with no single universal milligram target.
  • 75-100mg of testosterone cypionate or enanthate weekly is the most commonly cited evidence-based starting dose per Bhasin et al., 2020, NEJM. 150mg weekly as a first dose is aggressive.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Endocrine Society 2018 guidelines recommend starting testosterone at doses that achieve mid-normal serum levels (roughly 400-700 ng/dL), with no single universal milligram target.
  • 75-100mg of testosterone cypionate or enanthate weekly is the most commonly cited evidence-based starting dose per Bhasin et al., 2020, NEJM. 150mg weekly as a first dose is aggressive.
  • Three-month follow-up bloodwork is accurate and aligns with clinical monitoring standards. Any TRT provider not doing this is falling short of basic care.
  • The TRAVERSE trial (Lincoff et al., 2023, NEJM) found testosterone therapy did not significantly increase major cardiovascular events in hypogonadal men, but this applies to physiologic replacement, not high-dose optimization protocols.
  • "Optimized" is not a clinical term. Ask any TRT provider to name a specific target serum testosterone level and explain the evidence behind it before starting therapy.
  • Before any TRT dose is prescribed, baseline labs should include total and free testosterone, hematocrit, PSA, LH, FSH, and a metabolic panel. A clinic that skips this step is cutting corners.
  • Supraphysiologic testosterone levels increase the risk of erythrocytosis (elevated red blood cell mass), which raises clotting risk. Hematocrit monitoring is not optional.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @kmartfit actually say?

The creator, posting on behalf of Harley Meds, told viewers that "most men are getting started on anywhere between about 90 milligrams" up to "150 per week" of testosterone. They also said patients get a follow-up blood test three months in to confirm levels are in an "optimized range." The video ends with a call to switch clinics.

To be clear about what this is: this is a paid promotional video for a telehealth TRT clinic, not independent health education. The creator is actively recruiting patients with a comment-trigger funnel. That context matters when evaluating every claim made here.

Does the science back this up?

Partially. The 90-150mg weekly range is within real-world clinical practice, but framing it as a universal starting point glosses over significant individual variability and established guideline recommendations that often start lower.

The Endocrine Society's 2018 clinical practice guidelines recommend testosterone therapy be initiated at doses that bring serum testosterone into the mid-normal range, typically 400-700 ng/dL, without specifying a single milligram target. A 2020 review by Bhasin et al. in the New England Journal of Medicine noted that standard injectable testosterone cypionate or enanthate dosing typically ranges from 75-100mg weekly or 150-200mg every two weeks, with titration based on trough levels. So 90mg weekly is reasonable. But 150mg weekly as a starting dose is on the higher end and could push some men, particularly those with higher baseline sensitivity, into supraphysiologic ranges before any bloodwork has been reviewed.

The three-month follow-up bloodwork claim is consistent with Endocrine Society guidance, which recommends checking testosterone levels 3-6 months after initiating therapy.

What did they get wrong (or right)?

They got the general dosing ballpark mostly right, but the framing is sloppy in ways that matter clinically. Starting at 150mg weekly without first assessing baseline testosterone, hematocrit, PSA, or cardiovascular risk is not best practice. It is a number chosen for convenience, not precision.

The phrase "optimized range" is also doing a lot of work here without definition. "Optimized" is not a clinical term. The Endocrine Society talks about physiologic replacement, meaning restoring levels to what is normal for a healthy young adult male, not maximizing them. Clinics that use "optimized" language often target the upper-normal or even supraphysiologic range, which carries real risks: erythrocytosis, elevated hematocrit, cardiovascular strain, and suppressed fertility. A 2023 study by Lincoff et al. in NEJM (the TRAVERSE trial) found that testosterone therapy in men with hypogonadism did not increase major cardiovascular events compared to placebo, but that finding applies to physiologic replacement, not aggressive optimization.

The three-month blood test timeline is genuinely correct and worth acknowledging. That is standard, evidence-based follow-up practice.

What should you actually know?

TRT dosing is not one-size-fits-all, and any clinic that tells you otherwise before seeing your bloodwork should raise a flag. Starting dose should be based on your baseline testosterone level, your symptoms, your age, your hematocrit, and your cardiovascular history, not a standard intake protocol.

Injectable testosterone cypionate and enanthate are the most studied forms of TRT. Weekly dosing of 75-100mg is a common and well-supported starting point for most men, with upward titration only after confirming trough levels. Jumping to 150mg weekly from day one is aggressive and not universally appropriate.

The "optimized" framing used by many direct-to-consumer TRT clinics is a marketing term, not a medical one. Ask your provider what specific serum testosterone level they are targeting and why. A provider who cannot answer that question clearly is not practicing evidence-based medicine. If you are considering TRT, work with a provider who reviews your full labs, not just your total testosterone, before writing any prescription.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

KMART · TikTok creator

9.7K views on this video

Average dose of testosterone

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about endocrine society 2018 guidelines recommend starting testosterone at doses?

Endocrine Society 2018 guidelines recommend starting testosterone at doses that achieve mid-normal serum levels (roughly 400-700 ng/dL), with no single universal milligram target.

What does the video say about 75-100mg of testosterone cypionate?

75-100mg of testosterone cypionate or enanthate weekly is the most commonly cited evidence-based starting dose per Bhasin et al., 2020, NEJM. 150mg weekly as a first dose is aggressive.

What does the video say about three-month follow-up bloodwork?

Three-month follow-up bloodwork is accurate and aligns with clinical monitoring standards. Any TRT provider not doing this is falling short of basic care.

What does the video say about the traverse trial (lincoff et al., 2023, nejm) found testosterone?

The TRAVERSE trial (Lincoff et al., 2023, NEJM) found testosterone therapy did not significantly increase major cardiovascular events in hypogonadal men, but this applies to physiologic replacement, not high-dose optimization protocols.

What does the video say about "optimized"?

"Optimized" is not a clinical term. Ask any TRT provider to name a specific target serum testosterone level and explain the evidence behind it before starting therapy.

What does the video say about before any trt dose?

Before any TRT dose is prescribed, baseline labs should include total and free testosterone, hematocrit, PSA, LH, FSH, and a metabolic panel. A clinic that skips this step is cutting corners.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by KMART, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.